Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma

NCT05483257 · clinicaltrials.gov ↗

COMPLETED

Status

226

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer Resectable

Interventions

DEVICE: Multigene panel for next-generation sequencing

Sponsor

BAIYONG SHEN

Collaborators

[object Object]